Early-response multiple-parameter biodosimetry and dosimetry: risk predictions
Autor: | Matthias Port, Michael Abend, William F. Blakely |
---|---|
Rok vydání: | 2021 |
Předmět: |
Proteomics
medicine.medical_specialty biodosimetry Blutbild blood chemistry Blood Radiation effects Biodosimetry Humans Medicine Dosimetry Nuklearmedizin Sampling (medicine) ddc:610 cytogenetic dose assessment acute radiation syndrome (ARS) severity Blood chemical analysis Radiation Injuries Radiometry Acute radiation syndrome Waste Management and Disposal radioactivity contamination Chromosome Aberrations Strahlendosis business.industry Public Health Environmental and Occupational Health General Medicine Gold standard (test) Integrated approach Cytogenetic analysis Methods Triage Radioactivity Dose-response relationship Radiation Blood chemistry Radiological weapon Nuclear medicine Analysis physical dosimetry clinical signs and symptoms Dosimetrie Radiology business DDC 610 / Medicine & health |
Zdroj: | Journal of Radiological Protection. 41:R152-R175 |
ISSN: | 1361-6498 0952-4746 |
DOI: | 10.1088/1361-6498/ac15df |
Popis: | The accepted generic multiple-parameter and early-response biodosimetry and dosimetry assessment approach for suspected high-dose radiation (i.e. life-threatening) exposure includes measuring radioactivity associated with the exposed individual (if appropriate); observing and recording prodromal signs/symptoms; obtaining serial complete blood counts with white-blood-cell differential; sampling blood for the chromosome-aberration cytogenetic bioassay using the ‘gold standard’ dicentric assay (premature chromosome condensation assay for exposures >5 Gy photon acute doses equivalent), measurement of proteomic biomarkers and gene expression assays for dose assessment; bioassay sampling, if appropriate, to determine radioactive internal contamination; physical dose reconstruction, and using other available opportunistic dosimetry approaches. Biodosimetry and dosimetry resources are identified and should be setup in advance along with agreements to access additional national, regional, and international resources. This multifaceted capability needs to be integrated into a biodosimetry/dosimetry ‘concept of operations’ for use in a radiological emergency. The combined use of traditional biological-, clinical-, and physical-dosimetry should be use in an integrated approach to provide: (a) early-phase diagnostics to guide the development of initial medical-management strategy, and (b) intermediate and definitive assessment of radiation dose and injury. Use of early-phase (a) clinical signs and symptoms, (b) blood chemistry biomarkers, and (c) triage cytogenetics shows diagnostic utility to predict acute radiation injury severity. publishedVersion |
Databáze: | OpenAIRE |
Externí odkaz: |